A ribonolactone-based approach to the synthesis of 1'-carbon-substituted thymine ribonucleosides

Article abstract of DOI:10.1080/15257779408013242

Thymine ribonucleosides bearing a carbon substituent at the anomeric position were synthesized starting from D-ribonolactone by way of nucleophilic addition reaction of organolithium reagents and subsequent condensation with trimethylsilylated thymine.

Full text of DOI:10.1080/15257779408013242

This article was downloaded by: [University North Carolina - Chapel Hill]
On: 20 June 2013, At: 19:32
Publisher: Taylor & Francis
Informa Ltd Registered in England and Wales Registered Number: 1072954 Registered
office: Mortimer House, 37-41 Mortimer Street, London W1T 3JH, UK
Nucleosides and Nucleotides
Publication details, including instructions for authors and
subscription information:
http://www.tandfonline.com/loi/lncn19
A Ribonolactone-Based Approach to
the Synthesis of 1′-Carbon-Substituted
Thymine Ribonucleosides
Hiroyuki Hayakawa a , Michiko Miyazawa a , Hiromichi Tanaka a
Tadashi Miyasaka a
&
a School of Pharmaceutical Sciences, Showa University, Hatanodai
1-5-8, Shinagawa-ku, Tokyo, 142, Japan
Published online: 23 Sep 2006.
To cite this article: Hiroyuki Hayakawa , Michiko Miyazawa , Hiromichi Tanaka & Tadashi Miyasaka
(1994): A Ribonolactone-Based Approach to the Synthesis of 1′-Carbon-Substituted Thymine
Ribonucleosides, Nucleosides and Nucleotides, 13:1-3, 297-308
To link to this article: http://dx.doi.org/10.1080/15257779408013242
PLEASE SCROLL DOWN FOR ARTICLE
Full terms and conditions of use: http://www.tandfonline.com/page/terms-and-conditions
This article may be used for research, teaching, and private study purposes. Any
substantial or systematic reproduction, redistribution, reselling, loan, sub-licensing,
systematic supply, or distribution in any form to anyone is expressly forbidden.
The publisher does not give any warranty express or implied or make any representation
that the contents will be complete or accurate or up to date. The accuracy of any
instructions, formulae, and drug doses should be independently verified with primary
sources. The publisher shall not be liable for any loss, actions, claims, proceedings,
demand, or costs or damages whatsoever or howsoever caused arising directly or
indirectly in connection with or arising out of the use of this material.